Upgrade to SI Premium - Free Trial

Unusual 11 Mid-Day Movers 7/25: (S) (SPHS) (NPTN) Higher; (TBRA) (STRP) (TCCO) Lower

July 25, 2016 12:56 PM
Tobira Therapeutics (Nasdaq: TBRA) 58.0% LOWER; announced results from CENTAUR, its Phase 2b clinical trial evaluating the efficacy and safety ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles